(NYSE: TFX) Teleflex's forecast annual revenue growth rate of 6.89% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.64%.
Teleflex's revenue in 2025 is $3,189,988,000.On average, 15 Wall Street analysts forecast TFX's revenue for 2025 to be $148,007,072,392, with the lowest TFX revenue forecast at $143,145,687,512, and the highest TFX revenue forecast at $155,299,149,712. On average, 15 Wall Street analysts forecast TFX's revenue for 2026 to be $163,563,504,008, with the lowest TFX revenue forecast at $157,111,120,440, and the highest TFX revenue forecast at $171,562,691,856.
In 2027, TFX is forecast to generate $170,457,831,656 in revenue, with the lowest revenue forecast at $161,574,755,648 and the highest revenue forecast at $180,401,573,456.